Bioblast Pharma Ltd. (ORPN) fell -5.09% or -0.15 to $2.8. It is close to 47574 shares traded, which is 9.25% compare to the average total volume 514336. The market cap of ORPN is $9.36 million. The year to date change is 32.88%. The 52 week price range is from $1.49 to $7.65. Price of ORPN have changed -1.01% during last week. It have changed 32.88% over last month, 29.39% over last 3 months, -12.97% over last 6 months and -57.86% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 2.41. It is -13.93% below current price. The 200-day Moving Averages for ORPN is 2.57. It is -8.21% below current price. The 52-week High is 7.65. It is 173.21% from the current price. The 52-week Low is 1.49. It is -46.79% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ORPN is 0.77 on 2018-01-12. Short % to float is 3.44%. There are some statistics of ORPN. It is has market cap $9.36 million. The share outstanding is 3.34 million. The average volume is 514336. The percent of top 15 Institution holding is 4.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -111.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -95.72%.